Irina Tsyganova, DPM
Podiatrist · Egg Harbor Township, NJNPI 1841448578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,528 and has fallen 71.8% since, to $431 in 2025.
Across 104 payments — averaging $53.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$560
- AbbVie$506
- Smith+Nephew$387
- Treace Medical Concepts, Inc.$350
- Paratek Pharmaceuticals, Inc.$348
- Stryker$314
- plus $3K from 27 others
What the payments were for
- Food & beverage$5,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 24 | $560 |
| AbbVie(2 entities) | 10 | $506 |
| Smith+Nephew | 11 | $387 |
| Treace Medical Concepts, Inc. | 5 | $350 |
| Paratek Pharmaceuticals, Inc. | 4 | $348 |
| Stryker(2 entities) | 4 | $314 |
| Amgen(2 entities) | 3 | $250 |
| Nevro Corp. | 2 | $246 |
| Medtronic | 2 | $243 |
| Paragon 28, Inc. | 3 | $236 |
| Zimmer Biomet | 2 | $213 |
| Kerecis Limited | 2 | $203 |
| Averitas Pharma Inc. | 3 | $153 |
| Abbott | 1 | $149 |
| Organogenesis Inc. | 2 | $147 |
| Cardiovascular Systems Inc. | 3 | $144 |
| GRT US Holding, Inc. | 5 | $137 |
| Gilead | 1 | $125 |
| Boston Scientific | 1 | $124 |
| Insmed, Inc. | 1 | $119 |
| Misonix Inc | 1 | $114 |
| Bard Peripheral Vascular, Inc. | 1 | $114 |
| Johnson & Johnson | 1 | $85 |
| Acera Surgical, Inc. | 2 | $72 |
| Next Science LLC | 1 | $47 |
| Zyla Life Sciences, Inc. | 2 | $29 |
| Bioventus LLC | 1 | $21 |
| Integra Lifesciences Corporation | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $14 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$657
- NUZYRA$332
- INTELLIS ADAPTIVESTIM$243
- DALVANCE$239
- KRYSTEXXA$233
- Kerecis Omega3 SurgiClose$164
- AUGMENT INJECTABLE$161
- ESPRIT$149
- Nextremity General Instrument$149
- Omnia$142
- Lapiplasty System$126
- Epclusa$125
- TMC PSI CUT GUIDE SYSTEM$125
- GENERAL ANGIOPLASTY$124
- Qutenza$122
- Cadence$121
- TEFLARO$115
- LUTONIX$114
- Senza$104
- JUBLIA$102
How this compares
$5,523 in reported general payments places this provider in the 85th percentile of 382 podiatrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 27 | $27,269 |
| Ammonium Lactate | 90 | $1,888 |
| Ketoconazole | 32 | $661 |
| Mupirocin | 111 | $582 |
| Ciclopirox | 24 | $484 |
| Diclofenac Sodium | 35 | $380 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 20 | $300 |
| Methylprednisolone | 44 | $220 |
| Gabapentin | 11 | $174 |
| Doxycycline Hyclate | 11 | $130 |
| Cephalexin | 15 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $560 | $27,26927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 382 podiatrist providers in New Jersey.
Other podiatrist in Egg Harbor Township
- Justin FlemingSomerset$1.2M
- Eric BaskinManahawkin$298K
- Jonathan RichardsEnglewood$79K
- Jack BondiSewell$53K
- Matthew WohlgemuthHammonton$49K
- Ritchard RosenEnglewood$44K
- Michael HuchitalLyndhurst$41K
- Jeffrey GewirtzPark Ridge$24K
- James SullivanSea Girt$19K
- Georgios KotziasParamus$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.